AEON Biopharma, Inc. (AEON) IPO — S-1 Filing, Stock & Insider Activity

AEON Biopharma, Inc. IPO — Status & S-1 Filing

Ticker: AEON
Status: Registered — S-1 filed with the SEC
S-1 filed: 2026-07-08
Exchange: NYSE
Expected price range: not yet disclosed (set in a later S-1/A or pricing amendment)
Shares offered: 17,479,373
SEC CIK: 0001837607 · View the S-1 on SEC EDGAR →

Track every registration update on the InsiderAlpha IPO tracker.

Updated Jul 16, 2026 · Last SEC filing 2026-06-22

AEON Biopharma, Inc. (AEON) has filed 5 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-22. 4 Form 8-K material event filings were reported by AEON in the last 90 days. InsiderAlpha tracks every AEON SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About AEON Biopharma, Inc. (AEON)

SEC CIK	0001837607

90-Day SEC Filing Activity

Form 4 filings (90d)	5
Form 8-K filings (90d)	4
Latest Form 4 filing	2026-06-22

Recent AEON Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2026-06-17	PALMISANO ROBERT J	Director	A — Grant or award	222.7K	$0.00	—	SEC
2026-06-17	Thunen Shelley B	Director	A — Grant or award	222.7K	$0.00	—	SEC
2026-06-17	Carter Eric G	Director	A — Grant or award	222.7K	$0.00	—	SEC
2026-06-17	FISCHER JOST	Director	A — Grant or award	222.7K	$0.00	—	SEC
2026-06-17	Forth Marc	Director	A — Grant or award	222.7K	$0.00	—	SEC
2026-04-02	Bencich John	CHIEF FINANCIAL OFFICER	A — Grant or award	754.7K	$0.00	—	SEC
2026-03-04	Oh Chad	CHIEF MEDICAL OFFICER	A — Grant or award	1.32M	$0.00	—	SEC
2026-03-04	Wilson Alexander Blair	CLO, CSO, and Corp Secretary	A — Grant or award	1.32M	$0.00	—	SEC
2026-03-04	Sy Jennifer	PRINCIPAL ACCOUNTING OFFICER	A — Grant or award	925.9K	$0.00	—	SEC
2026-02-17	Bancroft Robert E.	PRESIDENT & CEO	A — Grant or award	3.00M	$0.00	—	SEC
2026-02-17	Oh Chad	CHIEF MEDICAL OFFICER	A — Grant or award	862.5K	$0.00	—	SEC
2026-02-17	Sy Jennifer	PRINCIPAL ACCOUNTING OFFICER	A — Grant or award	575.0K	$0.00	—	SEC
2026-02-17	Wilson Alexander Blair	CLO, CSO, and Corp Secretary	A — Grant or award	862.5K	$0.00	—	SEC

All transactions sourced from SEC EDGAR Form 4 filings for AEON Biopharma, Inc. (AEON). Updated in real time as new filings are submitted to the SEC.

Most-Active AEON Insiders — Last 90 Days

Insider	Form 4 filings	Total transaction value
Thunen Shelley B	1	—
PALMISANO ROBERT J	1	—
Forth Marc	1	—
FISCHER JOST	1	—
Carter Eric G	1	—

Recent AEON Form 8-K Material Events

2026-07-15 — Item 1.01, 8.01, 9.01 [SEC]
2026-06-17 — Item 5.07 [SEC]
2026-05-14 — Item 7.01, 9.01 [SEC]
2026-05-14 — Item 2.02, 9.01 [SEC]
2026-04-03 — Item 3.01, 9.01 · Regulatory · negative [SEC]
AEON Biopharma received an additional written notice of non-compliance from NYSE American on March 31, 2026, indicating the company fails to meet continued listing standards due to a stockholders' deficit of approximately $55 million and net losses in three of four recent fiscal

Recent Insider Filings

2026-06-22 — Thunen Shelley B (Director)
2026-06-22 — PALMISANO ROBERT J (Director)
2026-06-22 — Forth Marc (Director)
2026-06-22 — FISCHER JOST (Director)
2026-06-22 — Carter Eric G (Director)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in AEON insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

AEON Insider Trading — FAQ

What is the latest insider trade for AEON?: AEON Biopharma, Inc. (AEON) had 5 insider filings in the last 90 days, with the most recent on 2026-06-22. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying AEON stock?: 0 insider purchases of AEON were filed in the last 90 days.
How many insiders are selling AEON stock?: 0 insider sales of AEON were filed in the last 90 days.
Where can I see AEON SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every AEON SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live AEON dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.